REMBURT

Welcome to the Brand page for “REMBURT”, which is offered here for In the statement, column 1, lines 4-6, pharmaceutical preprations for human use, preparations for the treatment of immunological, inflammatory and oncological diseases and disorders, and viral infections is deleted, and pharmaceutical preprations for human use for the treatment of systemic lupus erythematosus (sle), rheumatoid arthritis, osteroarthritis, cartilage injury, and infertility diseases and disorders, excluding parkinson and alzheimer's diseases is inserted.;[ pharmaceutical preprations for human use, preparations for the treatment of immunological, inflammatory and oncological diseases and disorders, and viral infections ] * pharmaceutical preprations for human use for the treatment of systemic lupus erythematosus (sle), rheumatoid arthritis, osteroarthritis, cartilage injury, and infertility diseases and disorders, excluding parkinson and alzheimer's diseases *;.

Its status is currently believed to be active. Its class is unavailable. “REMBURT” is believed to be currently owned by “Fresenius Kabi Deutschland GmbH”.